Plantar Fasciitis
Conditions
Keywords
Heel pain, plantar, fasciitis, foot pain
Brief summary
Randomized controlled trial of mixture of essential oils containing tea tree oil, rosemary, clove, pepper, in a formulation with skin permeation enhancers including limonene for the treatment of plantar fasciitis in adult men and women. Forty-two patients will be randomized to receive twice daily topical application of the treatment formulation or plain tea tree oil as a control. Analog pain scores will be assessed at the start of treatment and at two weeks. Analysis will be by student's T-test.
Detailed description
Randomized controlled trial of mixture of essential oils containing tea tree oil, rosemary, clove, pepper, in a formulation with skin permeation enhancers including limonene for the treatment of plantar fasciitis in adult men and women. Forty-two patients will be randomized to receive twice daily topical application of the treatment formulation or plain tea tree oil as a control. Analog pain scores will be assessed at the start of treatment and at two weeks. Analysis will be by student's T-test. Primary outcome measure will be the difference in pain score between baseline score and pain score at 2 weeks.
Interventions
OTHERTopical oil application
Topical Comparison
Sponsors
Center for Biomedical Research, Inc.
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Masking description
Identical bottles given to participants with serial number, aroma and feel of each treatment group is the same
Intervention model description
2 groups, plain tea tree oil control and formulated essential oil blend with permeation enhancer as treatment in a randomized trial
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
* Plantar fasciitis diagnosed by a medical practitioner and at least 3 months in duration
Exclusion criteria
* Age under 18 years, any history of diabetes, history of foot surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Pain Score Between Baseline and 2 Weeks | 2 weeks | Patients will be asked to rate pain on a 1-10 analog scale at the start of the study and at 2 weeks |
Countries
United States
Outcome results
None listed